Stifel expects the S&P 500 index to peak in the first half of 2025, then fall 10% to 15% in the second half of the year, the ...

Fintel reports that on December 16, 2024, Stifel upgraded their outlook for Denali Therapeutics (NasdaqGS:DNLI) from Hold to ...

Fintel reports that on December 16, 2024, Stifel downgraded their outlook for Alector (NasdaqGS:ALEC) from Buy to Hold.

Stifel upgraded Denali Therapeutics (DNLI) to Buy from Hold with a $37 price target Denali recently aligned with the FDA to file for ...

Stifel raised the firm’s price target on Viavi (VIAV) to $12 from $10.50 and keeps a Buy rating on the shares after the company announced a ...

Stifel Financial Corp lifted its holdings in shares of Cohen & Steers, Inc. (NYSE:CNS – Free Report) by 10.4% in the 3rd ...

Stifel Financial Corp boosted its stake in shares of Bank of Hawaii Co. (NYSE:BOH – Free Report) by 1.2% during the 3rd ...

The Stifel Snow Show continues to bring fans unparalleled access to every sport on the FIS World Cup circuit, including ...

The FDA has put a stop to U.S. initiation of PepGen’s Phase II trial for its Duchene muscular dystrophy treatment. The ...

The women of the Stifel U.S. Alpine Ski Team will make history this weekend when they race the iconic Birds of Prey downhill ...

Many Wall Street bears have retreated in the face of this year's blistering stock rally. The few that remain see a steep ...

There is potential for sentiment to improve in 2025, driven by recovery in FOXF’s high-margin bike business, Stifel analysts ...